pegylated tissue kallikrein-1 (QHRD106)
/ Qianhong Bio-Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
November 17, 2024
The first-in-human study of QHRD106 functioning as a safe and effective long-acting kallikrein drug potentially aiding ischemic stroke.
(PubMed, Expert Opin Investig Drugs)
- P1 | "This study provided initial evidence of potential treatment for ischemic strokes that the QHRD106 injection functioned as a safe and effective long-acting kallikrein drug. This study was registered on ClinicalTrials.gov with the identifier NCT06380699 and NCT06388772."
Clinical • Journal • P1 data • Cardiovascular • Ischemic stroke
1 to 1
Of
1
Go to page
1